Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Fujifilm beefs up its favipiravir supply chain

by Michael McCoy
April 24, 2020 | A version of this story appeared in Volume 98, Issue 16

 

Seeking to increase supply of Avigan, an influenza drug that may be effective against COVID-19, Fujifilm has signed up two pharmaceutical chemical outsourcing partners. The Japanese firm Kaneka says it will begin supplying the drug’s active ingredient, favipiravir, by July. Another Japanese firm, Ube Industries, says it will make intermediates for the drug. The Japanese government has ordered 2 million Avigan treatment courses.

C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support our journalism, become a member of ACS or sign up for C&EN's weekly newsletter.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.